Valuation: Becton, Dickinson and Company

Market Cap 53.16B 1,796B 47.69B 44.1B 39.94B 74.61B 5,063B 75.51B 527B 210B 2,649B 199B 195B 8,411B P/E 2026 *
38.7x
P/E 2027 * 23.1x
Enterprise Value 69.04B 2,332B 61.95B 57.27B 51.87B 96.91B 6,576B 98.08B 685B 273B 3,441B 259B 254B 10,924B EV / Sales 2026 *
3.58x
EV / Sales 2027 * 3.4x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 week+3.77%
Current month+7.84%
1 month+6.80%
3 months+25.00%
6 months+34.15%
Current year+8.91%
1 week 2.14
Extreme 2.14
2.26
1 month 1.97
Extreme 1.97
2.26
Current year 1.54
Extreme 1.54
2.36
1 year 1.54
Extreme 1.54
2.36
3 years 1.54
Extreme 1.54
2.36
5 years 1.54
Extreme 1.54
2.36
10 years 1.54
Extreme 1.54
2.36
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer - 2021-11-28
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.77% - - 53.12B
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 116B
+0.88%+1.88%+1.66%+36.51% 115B
-2.26%+2.24%-44.03%+5.76% 93.1B
-0.31%-4.72%-3.36%+72.86% 62.09B
-0.36%-0.25%+10.31%+83.70% 55.87B
+0.07%+0.42%+5.94%-22.43% 53.12B
+0.30%+1.70%-11.26%+43.83% 44.22B
+0.10%+3.08%-3.06%-8.71% 33.59B
Average -0.12%+2.27%-9.10%+26.46% 83.45B
Weighted average by Cap. -0.14%+2.37%-12.54%+24.14%

Financials

2026 *2027 *
Net sales 19.29B 652B 17.31B 16B 14.49B 27.07B 1,837B 27.4B 191B 76.2B 961B 72.39B 70.86B 3,052B 19.73B 666B 17.7B 16.36B 14.82B 27.69B 1,879B 28.02B 196B 77.93B 983B 74.03B 72.47B 3,121B
Net income 1.41B 47.51B 1.26B 1.17B 1.06B 1.97B 134B 2B 13.95B 5.56B 70.09B 5.28B 5.17B 223B 2.19B 74.05B 1.97B 1.82B 1.65B 3.08B 209B 3.11B 21.74B 8.66B 109B 8.23B 8.05B 347B
Net Debt 15.88B 537B 14.25B 13.18B 11.93B 22.29B 1,513B 22.56B 158B 62.75B 792B 59.61B 58.35B 2,513B 13.95B 471B 12.52B 11.57B 10.48B 19.58B 1,329B 19.82B 138B 55.11B 695B 52.35B 51.25B 2,207B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-10-28 THB 2.200 0.00% 27,889
26-10-27 THB 2.200 -0.90% 52,725
26-10-26 THB 2.220 +3.74% 153,867
26-10-22 THB 2.140 +0.94% 19,473
26-10-21 THB 2.120 -0.93% 3,812
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
195.16USD
Average target price
195.57USD
Spread / Average Target
+0.21%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company